Develops AI-powered digital tools and sensors to detect early cardiac disease and enable personalized, data-driven patient care.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Cardiosense is building a physiological waveform AI platform to develop predictive biomarkers to detect and manage cardiac disease. The Company has developed a suite of novel digital tools, multi-sensor devices, and analysis algorithms to detect early signs of cardiovascular disease, inform personalized therapy, and improve patient outcomes.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Cardiosense Management Team
Cardiosense Valuations & Financials
View real-time NPM data on Cardiosense stock including daily Cardiosense stock price estimates, valuation history, and historical share price information. Access Cardiosense financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Cardiosense pricing across six independent market signals. Looking for private company due diligence data sources on Cardiosense? Get in touch to learn more.
Similar Companies
like Cardiosense
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
PicsArt
Media & Entertainment
Creative platform providing tools for photo and video editing, graphic design, and digital content creation.
Outerbounds
AI & Machine Learning
Platform streamlines machine learning workflow development and management, enabling efficient model tracking, monitoring and optimization.
Lumeris
Healthcare & Life Sciences
Value-based care managed services operator for health systems and providers.
Kalibri Labs
Enterprise Software
A SaaS company that provides a benchmarking platform and reports to assess hotel performance in the digital marketplace.
Albert
FinTech
Comprehensive financial service that combines advanced technology with human expertise to automate and manage all aspects of personal finances.
MicroByre
Healthcare & Life Sciences
Engineering unconventional bacteria to convert biomass and waste into sustainable chemical feedstocks via precision fermentation.
Stability AI
AI & Machine Learning
Open-source AI company focused on developing groundbreaking technologies to benefit humanity.
Maven Machines
Commerce & Marketplaces
Delivers vehicle data analytics and safety insights to optimize operations and reduce risk.
FAQ
We have answers
Cardiosense stock does not trade on public stock exchanges. Cardiosense stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Cardiosense stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Cardiosense Stock does not trade on public stock exchanges. In order to sell Cardiosense shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Cardiosense does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Cardiosense share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Cardiosense stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Cardiosense stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Cardiosense stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Cardiosense is a private company and has not had an IPO. There is currently no Cardiosense IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Cardiosense IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
